1. Gastric Toxicity and Prostaglandin Content in Rats Dosed with Two Chemically Similar, Nonsteroidal Anti-Inflammatory Agents
- Author
-
Robert R. Brooks, Schwe Fang Pong, and Thomas J. Moorehead
- Subjects
Male ,medicine.medical_specialty ,medicine.drug_class ,Indomethacin ,Analgesic ,Prostaglandin ,6-Ketoprostaglandin F1 alpha ,Dinoprostone ,General Biochemistry, Genetics and Molecular Biology ,Anti-inflammatory ,Rats, Sprague-Dawley ,Structure-Activity Relationship ,chemistry.chemical_compound ,Internal medicine ,Edema ,medicine ,Gastric mucosa ,Animals ,Cyclooxygenase Inhibitors ,Lipoxygenase Inhibitors ,Rats, Wistar ,Prostaglandin E2 ,Furans ,Inflammation ,Sheep ,business.industry ,Stomach ,Anti-Inflammatory Agents, Non-Steroidal ,Seminal Vesicles ,Plants ,Rats ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Gastric Mucosa ,Toxicity ,Female ,Propionates ,medicine.symptom ,business ,medicine.drug - Abstract
Two chemically similar nonsteroidal anti-inflammatory drugs, orpanoxin and F-1067, had almost identical potencies and efficacies as anti-inflammatory (rat paw edema) and analgesic (mouse writhing) agents, but differed markedly in gastrotoxicity. Orpanoxin alone aggravated stomach lesions in rats subjected to pylorus ligation and failed to protect stomachs of rats challenged with indomethacin. The compounds did not differ in their in vitro enzyme inhibition effects, both failing to inhibit 5- and 15-lipoxygenase and both inhibiting prostaglandin synthetase. Extraction of prostagiandins from the gastric mucosa of pylorus-ligated rats revealed, however, that the safer F-1067 depleted prostaglandin 6-keto-F1α less and increased prostaglandin E2 much more than did orpanoxin. A possible causality is suggested.
- Published
- 1993
- Full Text
- View/download PDF